XML 97 R83.htm IDEA: XBRL DOCUMENT v3.10.0.1
Supplemental Consolidating Data (Cash Flows) (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jul. 01, 2018
Jun. 25, 2017
Jul. 01, 2018
Jun. 25, 2017
Dec. 31, 2017
Dec. 31, 2016
Condensed Cash Flow Statements, Captions [Line Items]            
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 1,029,683 $ 1,062,871 $ 1,029,683 $ 1,062,871 $ 746,210 $ 827,131
Cash flows from operating activities:            
Net income 242,338 258,867 417,101 445,236    
Adjustments to reconcile net income to net cash provided by operating activities:            
Depreciation and amortization of intangibles     130,061 107,578    
Amortization of deferred loan origination costs     39,396 40,771    
Amortization of financing origination fees     4,133 4,079    
Pension and Other Postretirement Benefits Cost (Reversal of Cost)     18,954 14,950    
Employee benefit plan contributions and payments     (6,422) (37,307)    
Stock compensation expense     19,081 17,497    
Net change in wholesale finance receivables related to sales     (171,195) (271,927)    
Provision for credit losses 18,880 26,217 48,932 69,806    
Deferred income taxes     1,515 178    
Other, net     20,894 (4,163)    
Changes in current assets and liabilities:            
Accounts receivable, net     (14,882) (28,239)    
Finance receivables - accrued interest and other     4,228 2,067    
Inventories     63,957 138,942    
Accounts payable and accrued liabilities     161,101 133,120    
Derivative instruments     (136) 3,114    
Other     (859) (8,634)    
Total adjustments     318,758 181,832    
Net cash provided by operating activities     735,859 627,068    
Cash flows from investing activities:            
Capital expenditures     (69,293) (69,816)    
Origination of finance receivables     (1,999,786) (1,977,839)    
Collections on finance receivables     1,712,884 1,647,799    
Other     (11,758) 7,031    
Net cash used by investing activities     (367,953) (392,825)    
Cash flows from financing activities:            
Proceeds from issuance of medium-term notes     1,144,018 893,668    
Repayments of medium-term notes     (877,488) (400,000)    
Repayments of securitization debt     (183,453) (275,659)    
Net increase (decrease) in credit facilities and unsecured commercial paper     56,280 (128,787)    
Borrowings of asset-backed commercial paper     120,903 341,625    
Repayments of asset-backed commercial paper     (100,660) (77,732)    
Dividends paid     (124,680) (128,452)    
Purchase of common stock for treasury     (111,227) (243,055)    
Issuance of common stock under employee stock option plans     1,965 7,432    
Net cash (used by) provided by financing activities     (74,342) (10,960)    
Effect of exchange rate changes on cash, cash equivalents and restricted cash     (10,091) 12,457    
Cash, cash equivalents and restricted cash:            
Net increase in cash, cash equivalents and restricted cash     283,473 235,740    
Reportable Legal Entities | Motorcycles And Related Products Operations            
Condensed Cash Flow Statements, Captions [Line Items]            
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 627,783 586,892 627,783 586,892 338,186 425,540
Cash flows from operating activities:            
Net income 181,579 208,900 419,908 469,345    
Adjustments to reconcile net income to net cash provided by operating activities:            
Depreciation and amortization of intangibles     127,935 104,157    
Amortization of deferred loan origination costs     0 0    
Amortization of financing origination fees     331 327    
Pension and Other Postretirement Benefits Cost (Reversal of Cost)     18,954 14,950    
Employee benefit plan contributions and payments     (6,422) (37,307)    
Stock compensation expense     17,229 15,995    
Net change in wholesale finance receivables related to sales     0 0    
Provision for credit losses 0 0 0 0    
Deferred income taxes     (443) 4,975    
Other, net     20,993 (6,422)    
Changes in current assets and liabilities:            
Accounts receivable, net     (194,831) (241,569)    
Finance receivables - accrued interest and other     0 0    
Inventories     63,957 138,942    
Accounts payable and accrued liabilities     137,644 112,916    
Derivative instruments     (205) 3,106    
Other     2,924 (8,683)    
Total adjustments     188,066 101,387    
Net cash provided by operating activities     607,974 570,732    
Cash flows from investing activities:            
Capital expenditures     (63,236) (64,273)    
Origination of finance receivables     0 0    
Collections on finance receivables     0 0    
Other     (11,758) 7,031    
Net cash used by investing activities     (74,994) (57,242)    
Cash flows from financing activities:            
Proceeds from issuance of medium-term notes     0 0    
Repayments of medium-term notes     0 0    
Repayments of securitization debt     0 0    
Net increase (decrease) in credit facilities and unsecured commercial paper     0 0    
Borrowings of asset-backed commercial paper     0 0    
Repayments of asset-backed commercial paper     0 0    
Dividends paid     (124,680) (128,452)    
Purchase of common stock for treasury     (111,227) (243,055)    
Issuance of common stock under employee stock option plans     1,965 7,432    
Net cash (used by) provided by financing activities     (233,942) (364,075)    
Effect of exchange rate changes on cash, cash equivalents and restricted cash     (9,441) 11,937    
Cash, cash equivalents and restricted cash:            
Net increase in cash, cash equivalents and restricted cash     289,597 161,352    
Reportable Legal Entities | Financial Services Operations            
Condensed Cash Flow Statements, Captions [Line Items]            
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 401,900 475,979 401,900 475,979 408,024 401,591
Cash flows from operating activities:            
Net income 60,926 50,108 107,339 82,015    
Adjustments to reconcile net income to net cash provided by operating activities:            
Depreciation and amortization of intangibles     2,126 3,421    
Amortization of deferred loan origination costs     39,396 40,771    
Amortization of financing origination fees     3,802 3,752    
Pension and Other Postretirement Benefits Cost (Reversal of Cost)     0 0    
Employee benefit plan contributions and payments     0 0    
Stock compensation expense     1,852 1,502    
Net change in wholesale finance receivables related to sales     0 0    
Provision for credit losses 18,880 26,217 48,932 69,806    
Deferred income taxes     2,043 (4,586)    
Other, net     (245) 2,134    
Changes in current assets and liabilities:            
Accounts receivable, net     0 0    
Finance receivables - accrued interest and other     4,228 2,067    
Inventories     0 0    
Accounts payable and accrued liabilities     192,410 228,247    
Derivative instruments     69 8    
Other     1,884 98    
Total adjustments     296,497 347,220    
Net cash provided by operating activities     403,836 429,235    
Cash flows from investing activities:            
Capital expenditures     (6,057) (5,543)    
Origination of finance receivables     (4,046,125) (4,205,868)    
Collections on finance receivables     3,593,272 3,608,929    
Other     0 0    
Net cash used by investing activities     (458,910) (602,482)    
Cash flows from financing activities:            
Proceeds from issuance of medium-term notes     1,144,018 893,668    
Repayments of medium-term notes     (877,488) (400,000)    
Repayments of securitization debt     (183,453) (275,659)    
Net increase (decrease) in credit facilities and unsecured commercial paper     56,280 (128,787)    
Borrowings of asset-backed commercial paper     120,903 341,625    
Repayments of asset-backed commercial paper     (100,660) (77,732)    
Dividends paid     (110,000) (106,000)    
Purchase of common stock for treasury     0 0    
Issuance of common stock under employee stock option plans     0 0    
Net cash (used by) provided by financing activities     49,600 247,115    
Effect of exchange rate changes on cash, cash equivalents and restricted cash     (650) 520    
Cash, cash equivalents and restricted cash:            
Net increase in cash, cash equivalents and restricted cash     (6,124) 74,388    
Eliminations            
Condensed Cash Flow Statements, Captions [Line Items]            
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 0 0 0 0 $ 0 $ 0
Cash flows from operating activities:            
Net income (167) (141) (110,146) (106,124)    
Adjustments to reconcile net income to net cash provided by operating activities:            
Depreciation and amortization of intangibles     0 0    
Amortization of deferred loan origination costs     0 0    
Amortization of financing origination fees     0 0    
Pension and Other Postretirement Benefits Cost (Reversal of Cost)     0 0    
Employee benefit plan contributions and payments     0 0    
Stock compensation expense     0 0    
Net change in wholesale finance receivables related to sales     (171,195) (271,927)    
Provision for credit losses $ 0 $ 0 0 0    
Deferred income taxes     (85) (211)    
Other, net     146 125    
Changes in current assets and liabilities:            
Accounts receivable, net     179,949 213,330    
Finance receivables - accrued interest and other     0 0    
Inventories     0 0    
Accounts payable and accrued liabilities     (168,953) (208,043)    
Derivative instruments     0 0    
Other     (5,667) (49)    
Total adjustments     (165,805) (266,775)    
Net cash provided by operating activities     (275,951) (372,899)    
Cash flows from investing activities:            
Capital expenditures     0 0    
Origination of finance receivables     2,046,339 2,228,029    
Collections on finance receivables     (1,880,388) (1,961,130)    
Other     0 0    
Net cash used by investing activities     165,951 266,899    
Cash flows from financing activities:            
Proceeds from issuance of medium-term notes     0 0    
Repayments of medium-term notes     0 0    
Repayments of securitization debt     0 0    
Net increase (decrease) in credit facilities and unsecured commercial paper     0 0    
Borrowings of asset-backed commercial paper     0 0    
Repayments of asset-backed commercial paper     0 0    
Dividends paid     110,000 106,000    
Purchase of common stock for treasury     0 0    
Issuance of common stock under employee stock option plans     0 0    
Net cash (used by) provided by financing activities     110,000 106,000    
Effect of exchange rate changes on cash, cash equivalents and restricted cash     0 0    
Cash, cash equivalents and restricted cash:            
Net increase in cash, cash equivalents and restricted cash     $ 0 $ 0